MYOS RENS Technology Inc.
45 Horsehill Road
About MYOS RENS Technology Inc.MYOS RENS is dedicated to developing innovative products that improve muscle mass, increase mobility and reduce frailty. MYOS RENS is a biotherapeutics and bionutrition company focused on the discovery, development and commercialization of products that improve human muscle health and performance.
Please click here for clinical trial information.
34 articles with MYOS RENS Technology Inc.
MYOS RENS Technology Announces Endorsement Partnership for Yolked® with Carli Lloyd, Two-Time Olympic Gold Medalist, FIFA Women's World Cup Champion, and Captain of the United States Women's National Soccer Team
MYOS RENS Technology Inc. announced their latest endorsement partnership with Carli Lloyd, an American superstar soccer player and two-time Olympic gold medalist, FIFA Women's World Cup champion, two-time FIFA Women's Player of the Year and three-time Olympian.
Company Presentation on Tuesday, June 4 at 3:40pm PT to Highlight its Core Nutritional Products
MYOS RENS Technology Reports 161% Increase in Revenues, 238% Increase in Gross Profit in First Quarter 2019
MYOS RENS Technology Inc. announced its financial results for the first quarter ended March 31, 2019.
Yolked® and MYOS Canine Muscle Formula® to be Distributed Nationwide
Conference Call to be Held Thursday, March 28, 2019 , at 11am ET
MYOS RENS Technology Announces the Date for the Release of Fourth Quarter and Fiscal Year 2018 Results, Conference Call and Webcast
MYOS RENS Technology Inc. announced that it will provide financial results for the fourth quarter and fiscal year 2018 on Wednesday, March 27, 2019 after the market closes.
MYOS RENS Technology Announces Initiation of a Study at Kansas State University to Evaluate the Impact of Fortetropin® on Quality of Life and Activity in Geriatric Dogs
MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition derived from fertilized egg yolk that helps build lean muscle, announced that it has signed an agreement with Kansas State University College of Veterinary Medicine
MYOS RENS Technology Inc. announced an endorsement partnership with NBA superstar Aaron Gordon of the Orlando Magic.
MYOS CEO Joseph Mannello Issues Letter to Shareholders Following Presentation at North American Veterinary Community (NAVC) Conference/VMX
Fortetropin's Benefits Demonstrated in Canine Recovery from Joint Surgery
MYOS RENS Technology Announces Study Results Demonstrating Fortetropin®, the Active Ingredient in Myos Canine Muscle Formula, Prevents Muscle Loss in Canines After Surgery and Enhances Recovery
Positive Results Obtained from Kansas State University Study
MYOS RENS Technology Announces Upcoming Presentation of Results from a Kansas State University Study Evaluating the Impact of Fortetropin® on Canine Muscle Loss after Surgery, at a Major Veterinary Conference, January 20, 2019
Results Relevant to Company's Veterinary and Human Nutrition Business
New Patent Will Significantly Enhance its Fortetropin® Intellectual Property Portfolio
MYOS RENS Technology Inc. issued the following letter to shareholders from MYOS CEO Joseph Mannello
ERIC ZALTAS JOINS BOARD OF DIRECTORS
MYOS RENS Technology Launches 'Yolked®', Its Sports Nutrition Product, With The Vitamin Shoppe® Nationwide
MYOS RENS Technology Inc. announced today that The Vitamin Shoppe® will distribute MYOS' muscle-enhancing sports nutrition product line, 'Yolked®' formulated with Fortetropin®.
Net Proceeds of $1.1 Million in Non-dilutive Funding Expected
MYOS RENS Technology Signs Distribution Agreement With Miller Veterinary Supply East To Bring Innovative MYOS Canine Muscle Formula™ To 6,000+ Veterinary Hospitals
First Distribution Agreement for MYOS Canine Muscle Formula™
MYOS RENS Technology Announces The Date For The Release Of Third Quarter 2018 Results, Conference Call And Webcast
MYOS RENS Technology Inc. announced today that it will provide financial results for the third quarter of 2018 on Tuesday, November 13 after the market closes.
MYOS RENS Technology To Exhibit MYOS Canine Muscle Formula™ At The Atlantic Coast Veterinary Conference, October 8-11, 2018
MYOS RENS Technology Inc. announced today that MYOS will exhibit at the Atlantic Coast Veterinary Conference in Atlantic City, NJ, from October 8-11, 2018.
MYOS RENS Technology Inc., a bionutrition company and owner of Fortetropin®, the natural food product that helps build lean muscle in conjunction with resistance training, announced today its financial results for the three months and six months ended June 30, 2018.